Certara, Inc. (CERT)
CERT Stock Price Chart
Explore Certara, Inc. interactive price chart. Choose custom timeframes to analyze CERT price movements and trends.
CERT Company Profile
Discover essential business fundamentals and corporate details for Certara, Inc. (CERT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
11 Dec 2020
Employees
1.49K
Website
https://www.certara.comCEO
William F. Feehery
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
CERT Financial Timeline
Browse a chronological timeline of Certara, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
EPS estimate is $0.15, while revenue estimate is $104.66M.
Earnings released on 6 Aug 2025
EPS came in at $0.07 falling short of the estimated $0.10 by -30.00%, while revenue for the quarter reached $104.57M , beating expectations by +0.47%.
Earnings released on 5 May 2025
EPS came in at $0.14 surpassing the estimated $0.13 by +7.69%, while revenue for the quarter reached $106.00M , beating expectations by +1.66%.
Earnings released on 26 Feb 2025
EPS came in at $0.15 surpassing the estimated $0.13 by +15.38%, while revenue for the quarter reached $100.36M , beating expectations by +1.24%.
Earnings released on 6 Nov 2024
EPS came in at $0.13 surpassing the estimated $0.11 by +18.18%, while revenue for the quarter reached $94.82M , missing expectations by -3.50%.
Earnings released on 6 Aug 2024
EPS came in at $0.07 falling short of the estimated $0.11 by -36.36%, while revenue for the quarter reached $93.31M , missing expectations by -2.85%.
Earnings released on 7 May 2024
EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $96.65M , beating expectations by +3.22%.
Earnings released on 29 Feb 2024
EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $88.01M , beating expectations by +1.63%.
Earnings released on 8 Nov 2023
EPS came in at $0.11 matching the estimated $0.11, while revenue for the quarter reached $85.58M , missing expectations by -1.18%.
Earnings released on 9 Aug 2023
EPS came in at $0.12 falling short of the estimated $0.13 by -7.69%, while revenue for the quarter reached $90.45M , missing expectations by -1.88%.
Earnings released on 8 May 2023
EPS came in at $0.12 matching the estimated $0.12, while revenue for the quarter reached $90.30M , missing expectations by -0.76%.
Earnings released on 1 Mar 2023
EPS came in at $0.16 surpassing the estimated $0.14 by +14.29%, while revenue for the quarter reached $86.63M , beating expectations by +4.95%.
Earnings released on 7 Nov 2022
EPS came in at $0.10 falling short of the estimated $0.11 by -9.09%, while revenue for the quarter reached $84.70M , beating expectations by +3.69%.
Earnings released on 9 Aug 2022
EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $82.76M , missing expectations by -3.16%.
Earnings released on 5 May 2022
EPS came in at $0.11 matching the estimated $0.11, while revenue for the quarter reached $81.55M , beating expectations by +2.09%.
Earnings released on 1 Mar 2022
EPS came in at $0.01 falling short of the estimated $0.09 by -88.89%, while revenue for the quarter reached $75.35M , missing expectations by -9.50%.
Earnings released on 9 Nov 2021
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $73.94M , beating expectations by +2.36%.
Earnings released on 5 Aug 2021
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $70.10M , beating expectations by +0.96%.
Earnings released on 6 May 2021
EPS came in at $0.06 surpassing the estimated $0.04 by +34.83%, while revenue for the quarter reached $66.72M , beating expectations by +25.00%.
Earnings released on 4 Mar 2021
EPS came in at $0.09 surpassing the estimated $0.03 by +170.03%, while revenue for the quarter reached $64.64M .
Earnings released on 14 Dec 2020
EPS came in at $0.02 , while revenue for the quarter reached $61.12M .
Earnings released on 30 Sept 2020
EPS came in at $0.01 , while revenue for the quarter reached $60.32M .
CERT Stock Performance
Access detailed CERT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.